Home > NRC Library > ADAMS Public Documents

07-35398-01 636206 Prelude Therapeutics Incorporated

Accession Number: ML23193A392

Date Released: Tuesday, August 22, 2023

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML23193A439 - Prelude Therapeutics Incorporated, License Amendment Request Ltr. dated June 1, 2023, w/o attachments (6/1/2023)
• ML23193A987 - Prelude Therapeutics Incorporated, NRC Form 532, Acknowledgement - Receipt of Correspondence dated July 12, 2023 (7/12/2023)
• ML23216A171 - Prelude Therapeutics Inc., Request for Additional Information (Telephone) dated August 3, 2023 (8/3/2023)
• ML24078A247 - Prelude Therapeutics Incorporated, License Amendment, Mail Control No. 636206 (8/14/2023)
• ML24078A250 - Prelude Therapeutics Incorporated, License Amendment No. 3, Mail Control No. 636206 (8/14/2023)